The Antibiotics Drug Market size is estimated to reach $45.18 Bn by 2025, growing at a CAGR of 3.23% during the forecast period 2020-2025. An antibiotic is an anti-microbial substance that is used to fight bacteria. Antibiotic drugs are the best antibacterial agents that are used for fighting bacterial infections and in the treatment of different types of infections. However, these antibiotics are not effective against viruses like the common cold or influenza. Antibiotics are taken by mouth in the form of capsules, syrups and were also taken in the form of injection when treated in the hospitals at severe conditions. An increase in diseases like skin infections, ear and sinus infections, bladder and kidney infection and other infections and rising funding by many manufactures for the research and development of new antibiotic drugs are driving the market during the forecast period 2020-2025.
Antibiotics Drug Market Segment Analysis – By Drug
The Drug segment of the Antibiotics Drug Market has Beta-lactams, Phenicols, Fluoroquinolone, Macrolides, Aminoglycosides, Sulfonamide, and Others. The Beta-lactams segment registered for the highest market share in 2019 and is set to continue for the forecast period 2020-2025, owing to the increased number of people suffering from different types of infections and beta-lactams have good antibacterial resistance. However, the others segment which includes tetracyclines, monoclonal antibodies, and lincosamides is anticipated to have the positive growth during the forecast period 2020-2025, owing to the developments being made in those sectors.
Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=15695
Report Price: $ 4500 (Single User License)
Antibiotics Drug Market Segment Analysis – By Drug origin
The global Antibiotics Drug Market based Drug Origin, can be further segmented into Natural, Synthetic, and Semi-Synthetic. The Natural segment under Drug origin held the highest market share in 2019. It is set to continue for the forecast period 2020-2025, owing to the increased health care awareness among the consumers towards the usage of the natural derived medicines than that of synthetic.
By Geography – Segment Analysis
The global Antibiotics Drug Market based on Geography, can be further segmented into North America, Asia-Pacific, Europe, and Rest of World. Asia-pacific had a dominant share in terms of revenue in 2019 and it is anticipated to hold the largest market share during the forecast period 2020-2025, owing to the increased prevalence of infectious diseases in countries like China and India. However, North America is estimated to outpace all the regions by clocking the highest CAGR during the forecast period 2020-2025 owing to the best health-care infrastructure and availability of many manufacturers in the region.
Drivers – Antibiotics Drug Market
Increase in R&D of new drugs
The increase in funding by the manufacturers for the development of new drugs s driving the global antibiotics drug market. An increase in the prevalence of infections and chronic diseases, acquisitions and collaborations by different manufacturers for the development of new drugs are some of the major factors that are driving the global antibiotics drug market growth during the forecast period 2020-2025.
Talk to one of our sales representative about the full report by providing your details in the link below:
Challenges – Antibiotics Drug Market
Strict regulations by the government
The strict regulations by the government for the approval of new drugs into the market is challenging the market. The side effects caused by the usage of antibiotic drugs and lack of awareness among the people about the usage of the antibiotic drugs are the factors which are hampering the growth of the market during the forecast period 2020-2025.
Antibiotics Drug Industry outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Antibiotics Drug Market. Key companies of this market are Pfizer, Inc, Abbott Laboratories, Merck & Co. Inc, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Tetraphase Pharmaceuticals Inc, Eli Lilly & Company, La Jolla Pharmaceuticals, and Astellas Pharma, Inc.
In August 2020, Merck & Co. Inc, has announced that it has entered into the licensing agreement with Hanmi Pharmaceuticals, to develop, manufacture, and commercialize efinopegdutide, which is used in the treatment of non-alcoholic steatohepatitis.
In January 2019, Tetraphase Pharmaceuticals Inc. announced the launch of the drug Xerava (eravacycline), this antibiotic drug is used for complicated intra-abdominal infections.
Geographically, Asia-Pacific’s Antibiotics Drug Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high prevalence of infectious diseases.
The increase in health concerns among people and increased prevalence of diseases like cancers, cardiovascular issues, and other infections are driving the market for Antibiotics Drug during the forecast period 2020-2025.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Antibiotics Drugs Market report.
The research and developments being made by different companies for the new type of antibiotic drugs are driving the growth of the market.
Related Reports :
A. Anti-Infective Drugs Market
B. Antibiotic Resistance Marke
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to email@example.com to discuss more about our consulting services.